Evidence map›Paper›PMID 40301663›Full record

ArticleBone marrow transplantation2025

Development of an Endothelial Activation and Stress Index (EASIX)-based predictive model for cytokine release syndrome and neurotoxicity after B-cell maturation antigen directed chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma.

Utkarsh Goel, Danai Dima, James A Davis, Aliya Rashid, William Wesson, Louis Williams, Sandra Mazzoni, Evguenia Bhurtel, Fauzia Ullah, Joslyn Rudoni and 7 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Utkarsh Goel *Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA. goelu@ccf.org.ORCID http://orcid.org/0000-0003-1663-0325
Danai Dima *University of Washington, Fred Hutchinson Cancer Center, Seattle, WA, USA.
James A DavisDepartment of Hematology/Medical Oncology, The Medical University of South Carolina, Charleston, SC, USA.ORCID http://orcid.org/0000-0001-7978-1652
Aliya RashidDivision of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, MO, USA.
William WessonDivision of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, MO, USA.ORCID http://orcid.org/0000-0002-9534-0512
Louis WilliamsDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Sandra MazzoniDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-7548-0705
Evguenia BhurtelDivision of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, MO, USA.
Fauzia UllahDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Joslyn RudoniDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Mikhaila RiceDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-4273-5780
Yun Kyoung Ryu TigerDivision of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Craig S SauterDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Faiz AnwerDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-6914-7439
Shahzad RazaDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Leyla ShuneDivision of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, MO, USA.
Jack KhouriDepartment of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-2473-6528

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40301663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.